Clinical outcomes among HR+/HER2− metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US
Crossref DOI link: https://doi.org/10.1186/s40164-015-0023-0
Published Online: 2015-12-12
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xie, Jipan
Hao, Yanni
Li, Nanxin
Lin, Peggy L.
Ohashi, Erika
Koo, Valerie
Wu, Eric Q.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (US) (none)